Pharmacy benefit managers took their turn in the spotlight last week, sending executives to Capitol Hill to testify that drugmakers are largely to blamefor ever-rising drug prices.
The PBMs have been under increasing pressure since President Donald Trump spoke last May about how his administration plans to wrangle the ballooning cost of prescription medicines as part of a broader effort to curb U.S. healthcare spending overall.
"We're very much eliminating the middlemen," Trump said from the White House lawn nearly a year ago, with Health and Human Services Secretary Alex Azar by his side.
Print Page
Email to a Friend